生物保存市场 - 全球产业规模、份额、趋势、机会和预测，按产品、应用、地区和竞争细分，2019-2029F

2023 年全球生物保鲜市场价值为 18.7 亿美元，预计到 2029 年预测期内将稳定成长，复合年增长率为 9.12%。它有效地延长了生物样本的生存能力并保护它们免受环境破坏。生物样本（例如尿液、组织、血液、DNA、细胞等）储存在生物储存库中，以供未来研究或实验室测试之用。生物保存有两种主要类型：生物保存介质和生物保存设备。后者包括保存生物样本的工具，包括生物基疗法、细胞、临床生物标记、诊断生物晶片、病毒等。值得注意的是，生物保存设备通常用于处理各种生物样本，如人体组织样本、干细胞、器官等。生物保存市场的成长受到多种因素的推动，包括医疗保健支出的改善、实验室和医院内部样本储存的实施以及研发 (R&D) 投资的增加。生物保存在推动再生医学方面发挥着至关重要的作用，对组织和细胞保存的需求不断增长，促使对基于生物保存的製药业务的投资增加。

市场概况
预测期	2025-2029
2023 年市场规模	18.7亿美元
2029 年市场规模	31.4亿美元
2024-2029 年复合年增长率	9.12%
成长最快的细分市场	媒体
最大的市场	北美洲

主要市场驱动因素

增加研发投资

生物银行的进展

对个人化医疗的需求不断增长

再生医学研究投资不断增加

主要市场挑战

伦理道德问题

生物保存活动成本高昂

主要市场趋势

生物银行中干细胞储存的出现

增加药物发现应用

细分市场洞察

产品洞察

应用洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球生物保存市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品{设备（冰柜、冰箱、消耗品）、介质（预配製、自製）、LIMS}
  • 依应用{再生医学（细胞疗法、基因疗法等）、生物库（人类卵子、人类精子、兽医体外受精）、药物发现}
  • 按地区
  • 按公司划分 (2023)
• 市场地图

第 6 章：北美生物保存市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲生物保存市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区生物保存市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲生物保存市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲生物保存市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按申请
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球生物保存市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• BioCision LLC
• BioLife Solutions Inc.
• ThermoGenesis Holdings, Inc.
• Custom Biogenic Systems Inc.
• Lifeline Scientific Inc.
• Merck KGaA
• Princeton CryoTech Inc.
• VWR International, LLC
• Azenta US Inc.
• Koninklijke DSM NV

第 16 章：策略建议

第17章调查会社について・免责事项

Global Bio Preservation Market was valued at USD 1.87 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 9.12% through 2029. Bio preservation utilizes microorganisms and their metabolic by-products to enhance food safety and prolong shelf life. It effectively extends the viability of biospecimens and safeguards them from environmental damage. Biospecimens, such as urine, tissue, blood, DNA, cells, and more, are stored in a bio repository for future research or laboratory testing purposes. There are two primary types of bio preservation: bio-preservation media and bio-preservation equipment. The latter comprises tools that preserve biospecimens including bio-based therapeutics, cells, clinical biomarkers, diagnostic biochips, viruses, and others. Notably, bio-preservation equipment is commonly employed in processing various biospecimens like human tissue samples, stem cells, organs, and more. The market growth of bio preservation is driven by several factors, including the improvement of healthcare expenditure, the implementation of in-house sample storage in laboratories and hospitals, and increased investment in research and development (R&D). Bio preservation plays a critical role in advancing regenerative medicine, and the rising demand for tissue and cell preservation has prompted increased investment in bio preservation-based pharmaceutical businesses.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 1.87 Billion
Market Size 2029	USD 3.14 Billion
CAGR 2024-2029	9.12%
Fastest Growing Segment	Media
Largest Market	North America

Key Market Drivers

Increasing Investments in Research and Developments

The growth of the biopharmaceutical industry is a significant driver impacting the market. This sector specializes in the development and manufacturing of biological drugs, encompassing therapeutic proteins, antibodies, vaccines, and cell-based therapies. Bio preservation plays a crucial role in safeguarding the stability, quality, and integrity of these intricate biological products throughout their life cycle, spanning from development to distribution. Given the sensitivity of biological drugs to environmental conditions, including temperature, light, and moisture, there has been a substantial surge in the demand for preservation techniques that are indispensable for upholding the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other suitable preservation methods, biopharmaceutical companies can prolong the shelf life of their products, ensuring their efficacy and safety upon administration to patients. Significant investments have been made by both private and public organizations in research and development endeavors related to the development of new medications, which hold the potential to combat the rising number of chronic diseases. The substantial increase in funding aims to enhance access to advanced medical care and cutting-edge products, including state-of-the-art bio preservation facilities. The expanding number of biobanks, particularly those dedicated to biospecimen storage, presents promising opportunities for the bio preservation market. Governments worldwide are implementing various measures to promote cell therapies for the treatment of diverse diseases. Government healthcare initiatives encompass grants, contracts, and financial support for research activities, leading to a surge in research and development expenditures by organizations.

Advances In Bio banking

The rising demand for biobanking has a significant impact on the global market. Biobanks serve as repositories for various biological samples, including cells, tissues, blood, DNA, and other biomaterials, used for research and diagnostic purposes. These techniques play a crucial role in preserving the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The increasing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the biobanks segment worldwide. The growing focus on precision medicine and personalized healthcare has underscored the importance of biobanks, as they provide a comprehensive collection of samples for genomic testing, biomarker discovery, and the development of tailored treatments. Advances in bio-preservation techniques ensure the long-term stability and integrity of biological samples. Researchers rely on preserved samples for longitudinal studies and retrospective analyses, driving the demand for methods that maintain sample quality over time. Biobanks play a crucial role in medical and scientific research. The use of well-preserved samples enhances research quality and reproducibility, making advanced bio-preservation methods a necessity. Biobanks support a wide range of biomedical research, including biomarker discovery, drug development, and disease mechanisms. Effective bio-preservation ensures that samples remain viable for a multitude of research applications.

Growing Demand for Personalized Medicine

The increasing demand for personalized medicine is driving the growth of the bio preservation market. The significant unmet medical need for developing effective therapies for various diseases and conditions has fueled the demand for personalized medicine, consequently driving the need for bio preservation. Market players may find themselves in a strategically advantageous position in this scenario. Personalized medicine, which considers individual needs and preferences, is gaining momentum as individuals increasingly store their tissues and stem cells for potential future treatments. The availability of individual samples, accompanied by annotated clinical and pathological data, is a crucial requirement in personalized medicine. Research organizations are actively exploring the potential of developing personalized treatments using bio samples. Biobanking, a form of bio preservation, plays a vital role in personalized medicine and genomics research. As a result, the growing demand for personalized medicine will fuel the worldwide demand for bio preservation and drive market growth.

Rising Investments in Research of Regenerative Medicine

Advancements in regenerative medicine exert a significant influence on the global market. Bio preservation plays a pivotal role in the success of regenerative medicine by safeguarding the viability and functionality of cells, tissues, and engineered constructs. The objective of regenerative medicine is to restore or replace damaged tissues or organs through cell-based therapies, tissue engineering, and innovative approaches. These techniques are vital for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future therapeutic or research purposes. Progress in stem cell preservation protocols and cryoprotectants has improved the viability and post-thaw functionality of stem cells, thereby contributing to market growth.

Key Market Challenges

Ethical Issues

Ethical concerns pose significant challenges in the bio preservation market. The issue of privacy when accessing biological samples remains a prominent ethical concern, as safeguarding the identity of individuals is of utmost importance. Obtaining informed consent serves as the initial step towards ensuring protection. Private companies operating in this market may attempt to exploit biobank information for their own interests. Ethical deliberations regarding the preservation of biological samples have been subject to ongoing discussions for numerous years. Research conducted in the field of biological specimens, such as tissues and stem cells, also faces scrutiny in several countries. Noteworthy ethical issues encompass the cloning of embryonic stem cells and the destruction of embryos in order to establish cell lines. The safety concerns, scientific integrity, and acceptance of using Human Embryo Stem Cell Lines in research remain topics of debate. These factors may impede the growth of the global bio preservation market during the forecast period.

High Costs of Bio preservation Activities

Bio preservation is an advanced preservation technology that involves significant expenses due to the utilization of costly processes and equipment throughout the preservation process. Stability concerns arise from tissue damage during freezing and thawing. The introduction of low-cost preservation procedures, such as room temperature preservation processes, is anticipated to impede market growth.

Key Market Trends

Emergence Of Stem Cell Storage in Biobanks

The bio preservation market is experiencing a significant trend with the emergence of stem cell storage in biobanks. The demand for stem cell storage in biobanks is witnessing remarkable growth, positively impacting the global bio preservation market's expansion in the forecast period. In disciplines like cardiology and oncology, scientists recognize the potential of stem cells to address unmet needs. Consequently, the market is witnessing the establishment of numerous biobanking facilities dedicated to stem cell research. Research organizations are actively focused on establishing advanced production or manufacturing units to enhance supply chain efficiency, thereby increasing production capacities. For instance, the adoption of IT in logistics facilitates the monitoring of biobanking services, while the development of temperature-controlled logistics solutions, such as cryopreservation, minimizes manual errors and enables the production of large batches of stem cell therapy products in a closed, sterile environment. These factors present substantial growth opportunities for the global bio preservation market in the forecast period.

Increasing Drug Discovery Applications

Drug discovery applications is also playing a significant role in positively influencing the market and driving the demand for these technologies and solutions. Given that drug discovery heavily relies on the utilization of cell lines and primary cells for screening, testing, and studying the effectiveness and safety of potential drug candidates, the importance of these technologies and equipment cannot be overstated. They are crucial for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The accurate and efficient preservation and retrieval of these samples are paramount for conducting large-scale screening campaigns, thus expediting the drug discovery process.

Segmental Insights

Product Insights

Based on Product, Media have emerged as the fastest growing segment in the Global Bio Preservation Market in 2023. The substantial share of this segment can be attributed to the increasing research activities in stem cell therapy, regenerative medicine, and personalized medicine. Bio preservation media plays a vital role in stem cell therapy and the preservation of transplanted organs. Nutrient media are extensively utilized in tissue engineering, particularly in stem cell storage. Ensuring a continuous supply of oxygen and nutrition diffusion is crucial during the initial stages of stem cell culture. Stem cell engineering has long been employed in the treatment of bone defects.

Application Insights

Based on Application, Regenerative Medicine have emerged as the dominating segment in the Global Bio Preservation Market in 2023. The advancements in the fields of regenerative medicine and personalized medicine, along with the growing trend in cord blood banking, are all contributing to the development of this segment. The significant share of this segment can be attributed to the high prevalence of chronic diseases globally, as well as the advancements in treatment methods. Regenerative Medicine emerged as the dominant segment in the Global Bio Preservation Market due to several key factors driving its growth and adoption. One significant factor is the increasing prevalence of chronic diseases and age-related disorders, which has propelled the demand for regenerative therapies aimed at repairing or replacing damaged tissues and organs. The rising geriatric population worldwide, coupled with the escalating burden of chronic conditions such as cardiovascular diseases, diabetes, and neurological disorders, has fueled the need for innovative regenerative solutions.

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Bio Preservation Market in 2023. Key drivers of this market's growth include increased research activities in regenerative medicine, rising R&D investments in life sciences research, and growing awareness of personalized medicine. These factors are propelled by the constant discovery of new drugs and the introduction of advanced therapies in the biomedical research sector. The demand for high-quality care for patients with chronic diseases, coupled with the continuous discovery of new drugs and the emergence of advanced therapies, further contribute to the development of this industry. In North America, the demand for blood, solid tissue specimens (including paraffin-embedded or frozen bio-specimens of tumors), and other tissues (such as peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives) is driven by various research institutes, pathological centers, and hospitals. This growth is supported by favorable government regulations. Asia Pacific is projected to witness the fastest growth in the bio preservation media and equipment industry. This can be attributed to increasing public and private investments in life sciences research, the rising number of biobanks and research centers, and the high prevalence of chronic diseases in the region.

Key Market Players

BioCision LLC

BioLife Solutions Inc.

ThermoGenesis Holdings, Inc.

Custom Biogenic Systems Inc.

Lifeline Scientific Inc.

Merck KGaA

Princeton CryoTech Inc.

VWR International, LLC

Azenta US Inc.

Koninklijke DSM N.V.

Report Scope:

In this report, the Global Bio Preservation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio Preservation Market, By Product:

Equipment

Freezers

Refrigerators

Consumables

Media

Pre-formulated

Home-brew

LIMS

Bio Preservation Market, By Application:

Regenerative Medicine

Cell therapy

Gene therapy

Others

Bio-banking

Human eggs

Human sperms

Veterinary IVF

Drug Discovery

Bio Preservation Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio Preservation Market.

Available Customizations:

Global Bio Preservation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio Preservation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product {Equipment (Freezers, Refrigerators, Consumables), Media (Pre-formulated, Home-brew), LIMS}
  • 5.2.2. By Application {Regenerative Medicine (Cell therapy, Gene therapy, Others), Bio-banking (Human eggs, Human sperms, Veterinary IVF), Drug Discovery}
  • 5.2.3. By Region
  • 5.2.4. By Company (2023)
• 5.3. Market Map

6. North America Bio Preservation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bio Preservation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Bio Preservation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Bio Preservation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Bio Preservation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bio Preservation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Bio Preservation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Bio Preservation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. France Bio Preservation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Bio Preservation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Bio Preservation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bio Preservation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Bio Preservation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Bio Preservation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Bio Preservation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Bio Preservation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Bio Preservation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bio Preservation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Bio Preservation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Bio Preservation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Bio Preservation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bio Preservation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Bio Preservation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Bio Preservation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Bio Preservation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. BioCision LLC
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. BioLife Solutions Inc.
• 15.3. ThermoGenesis Holdings, Inc.
• 15.4. Custom Biogenic Systems Inc.
• 15.5. Lifeline Scientific Inc.
• 15.6. Merck KGaA
• 15.7. Princeton CryoTech Inc.
• 15.8. VWR International, LLC
• 15.9. Azenta US Inc.
• 15.10. Koninklijke DSM N.V.

16. Strategic Recommendations

17. About Us & Disclaimer